We've found
17,797
archived clinical trials in
Peripheral Vascular Disease
We've found
17,797
archived clinical trials in
Peripheral Vascular Disease
Whole-Body Cooling for Birth Asphyxia in Term Infants
Updated: 12/31/1969
Randomized Controlled Trial of Hypothermia for Hypoxic-Ischemic Encephalopathy in Term Infants
Status: Enrolling
Updated: 12/31/1969
Whole-Body Cooling for Birth Asphyxia in Term Infants
Updated: 12/31/1969
Randomized Controlled Trial of Hypothermia for Hypoxic-Ischemic Encephalopathy in Term Infants
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Whole-Body Cooling for Birth Asphyxia in Term Infants
Updated: 12/31/1969
Randomized Controlled Trial of Hypothermia for Hypoxic-Ischemic Encephalopathy in Term Infants
Status: Enrolling
Updated: 12/31/1969
Whole-Body Cooling for Birth Asphyxia in Term Infants
Updated: 12/31/1969
Randomized Controlled Trial of Hypothermia for Hypoxic-Ischemic Encephalopathy in Term Infants
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Whole-Body Cooling for Birth Asphyxia in Term Infants
Updated: 12/31/1969
Randomized Controlled Trial of Hypothermia for Hypoxic-Ischemic Encephalopathy in Term Infants
Status: Enrolling
Updated: 12/31/1969
Whole-Body Cooling for Birth Asphyxia in Term Infants
Updated: 12/31/1969
Randomized Controlled Trial of Hypothermia for Hypoxic-Ischemic Encephalopathy in Term Infants
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Whole-Body Cooling for Birth Asphyxia in Term Infants
Updated: 12/31/1969
Randomized Controlled Trial of Hypothermia for Hypoxic-Ischemic Encephalopathy in Term Infants
Status: Enrolling
Updated: 12/31/1969
Whole-Body Cooling for Birth Asphyxia in Term Infants
Updated: 12/31/1969
Randomized Controlled Trial of Hypothermia for Hypoxic-Ischemic Encephalopathy in Term Infants
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Whole-Body Cooling for Birth Asphyxia in Term Infants
Updated: 12/31/1969
Randomized Controlled Trial of Hypothermia for Hypoxic-Ischemic Encephalopathy in Term Infants
Status: Enrolling
Updated: 12/31/1969
Whole-Body Cooling for Birth Asphyxia in Term Infants
Updated: 12/31/1969
Randomized Controlled Trial of Hypothermia for Hypoxic-Ischemic Encephalopathy in Term Infants
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Whole-Body Cooling for Birth Asphyxia in Term Infants
Updated: 12/31/1969
Randomized Controlled Trial of Hypothermia for Hypoxic-Ischemic Encephalopathy in Term Infants
Status: Enrolling
Updated: 12/31/1969
Whole-Body Cooling for Birth Asphyxia in Term Infants
Updated: 12/31/1969
Randomized Controlled Trial of Hypothermia for Hypoxic-Ischemic Encephalopathy in Term Infants
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Whole-Body Cooling for Birth Asphyxia in Term Infants
Updated: 12/31/1969
Randomized Controlled Trial of Hypothermia for Hypoxic-Ischemic Encephalopathy in Term Infants
Status: Enrolling
Updated: 12/31/1969
Whole-Body Cooling for Birth Asphyxia in Term Infants
Updated: 12/31/1969
Randomized Controlled Trial of Hypothermia for Hypoxic-Ischemic Encephalopathy in Term Infants
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comparison of Orbital Versus Rotational Atherectomy Effects On Coronary Microcirculation in PCI
Updated: 12/31/1969
Comparison of Orbital Versus Rotational Atherectomy Effects On Coronary Microcirculation in Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 12/31/1969
Comparison of Orbital Versus Rotational Atherectomy Effects On Coronary Microcirculation in PCI
Updated: 12/31/1969
Comparison of Orbital Versus Rotational Atherectomy Effects On Coronary Microcirculation in Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Evaluation of a Clinical Algorithm With Turbo-Power Following Treatment of Specific Morphologies
Updated: 12/31/1969
REX - A Pilot Evaluation of a Clinical Algorithm With Turbo-Power Following Treatment of Specific Morphologies
Status: Enrolling
Updated: 12/31/1969
An Evaluation of a Clinical Algorithm With Turbo-Power Following Treatment of Specific Morphologies
Updated: 12/31/1969
REX - A Pilot Evaluation of a Clinical Algorithm With Turbo-Power Following Treatment of Specific Morphologies
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting
Updated: 12/31/1969
Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting
Status: Enrolling
Updated: 12/31/1969
Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting
Updated: 12/31/1969
Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions
Updated: 12/31/1969
Turbo Power Laser Atherectomy Combined With Drug Coated Balloon Angioplasty for the Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions
Status: Enrolling
Updated: 12/31/1969
TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions
Updated: 12/31/1969
Turbo Power Laser Atherectomy Combined With Drug Coated Balloon Angioplasty for the Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Utility of Endothelial Dysfunction in PAD
Updated: 12/31/1969
Clinical Utility of Endothelial Dysfunction in PAD
Status: Enrolling
Updated: 12/31/1969
Clinical Utility of Endothelial Dysfunction in PAD
Updated: 12/31/1969
Clinical Utility of Endothelial Dysfunction in PAD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Data Analyses for Ancillary WISE Femhrt Hormone Replacement Study
Updated: 12/31/1969
WISE Ancillary Study Data Analyses: Efficacy of Hormone Replacement on Myocardial Ischemia in Postmenopausal Women With Normal/Minimal Coronary Artery Disease: Data Analysis
Status: Enrolling
Updated: 12/31/1969
Data Analyses for Ancillary WISE Femhrt Hormone Replacement Study
Updated: 12/31/1969
WISE Ancillary Study Data Analyses: Efficacy of Hormone Replacement on Myocardial Ischemia in Postmenopausal Women With Normal/Minimal Coronary Artery Disease: Data Analysis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Macronutrients and Heart Disease Risk
Updated: 12/31/1969
Macronutrient Composition of Diet and Risk Factors for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
Study of Macronutrients and Heart Disease Risk
Updated: 12/31/1969
Macronutrient Composition of Diet and Risk Factors for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Using Beta Blockers to Treat Mitral Regurgitation
Updated: 12/31/1969
Beta-Blockade in Chronic Mitral Regurgitation: Moving From the Laboratory Experiment to Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Using Beta Blockers to Treat Mitral Regurgitation
Updated: 12/31/1969
Beta-Blockade in Chronic Mitral Regurgitation: Moving From the Laboratory Experiment to Clinical Investigation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Updated: 12/31/1969
Evaluation of the Gore(R) Viabahn(R) Balloon Expandable Endoprosthesis (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients.
Updated: 12/31/1969
Clinical Utility of an Age, Sex and Gene Expression Score (ASGES or Corus CAD) in the Diagnostic Management of Obstructive Coronary Artery Disease in African American Patients in a Primary Care Setting
Status: Enrolling
Updated: 12/31/1969
Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients.
Updated: 12/31/1969
Clinical Utility of an Age, Sex and Gene Expression Score (ASGES or Corus CAD) in the Diagnostic Management of Obstructive Coronary Artery Disease in African American Patients in a Primary Care Setting
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
Updated: 12/31/1969
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
Updated: 12/31/1969
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
Updated: 12/31/1969
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
Updated: 12/31/1969
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
Updated: 12/31/1969
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
Updated: 12/31/1969
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
Updated: 12/31/1969
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
Updated: 12/31/1969
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
Updated: 12/31/1969
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
Updated: 12/31/1969
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
Updated: 12/31/1969
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
Updated: 12/31/1969
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
Updated: 12/31/1969
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
Updated: 12/31/1969
A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials